Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS

Novavax (NASDAQ:NVAX – Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.76) EPS for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.11, Briefing.com reports. The firm had revenue of $84.51 million during the quarter, compared to the consensus estimate of $65.80 million. During the same quarter in […]

Leave a Reply

Your email address will not be published.

Previous post Xenon Pharmaceuticals (NASDAQ:XENE) Posts Earnings Results, Beats Estimates By $0.01 EPS
Next post Cogent Biosciences (NASDAQ:COGT) Issues Earnings Results